Literature DB >> 2677404

Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.

G W Wertz1, M Krieger, L A Ball.   

Abstract

The synthesis of the extensively O-glycosylated attachment protein, G, of human respiratory syncytial virus and its expression on the cell surface were examined in a mutant Chinese hamster ovary (CHO) cell line, ldlD, which has a defect in protein O glycosylation. These cells, used in conjunction with an inhibitor of N-linked oligosaccharide synthesis, can be used to establish conditions in which no carbohydrate addition occurs or in which either N-linked or O-linked carbohydrate addition occurs exclusively. A recombinant vaccinia virus expression vector for the G protein was constructed which, as well as containing the human respiratory syncytial virus G gene, contained a portion of the cowpox virus genome that circumvents the normal host range restriction of vaccinia virus in CHO cells. The recombinant vector expressed high levels of G protein in both mutant ldlD and wild-type CHO cells. Several immature forms of the G protein were identified that contained exclusively N-linked or O-linked oligosaccharide side chains. Metabolic pulse-chase studies indicated that the pathway of maturation for the G protein proceeds from synthesis of the 32-kilodalton (kDa) polypeptide accompanied by cotranslational attachment of high-mannose N-linked sugars to form an intermediate with an apparent mass of 45 kDa. This step is followed by the Golgi-associated conversion of the N-linked sugars to the complex type and the completion of the O-linked oligosaccharides to achieve the mature 90-kDa form of G. Maturation from the 45-kDa N-linked form to the mature 90-kDa form occurred only in the presence of O-linked sugar addition, confirming that O-linked oligosaccharides constitute a significant proportion of the mass of the mature G protein. In the absence of O glycosylation, forms of G bearing galactose-deficient truncated N-linked and fully mature N-linked oligosaccharides were observed. The effects of N- and O-linked sugar addition on the transport of G to the cell surface were measured. Indirect immunofluorescence and flow cytometry showed that G protein could be expressed on the cell surface in the absence of either O glycosylation or N glycosylation. However, cell surface expression of G lacking both N- and O-linked oligosaccharides was severely depressed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677404      PMCID: PMC251114     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge.

Authors:  E J Stott; L A Ball; K K Young; J Furze; G W Wertz
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

2.  Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.

Authors:  S Levine; R Klaiber-Franco; P R Paradiso
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

3.  Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.

Authors:  D K Wagner; D L Nelson; E E Walsh; C B Reimer; F W Henderson; B R Murphy
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

Authors:  E J Stott; G Taylor; L A Ball; K Anderson; K K Young; A M King; G W Wertz
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.

Authors:  M Satake; J E Coligan; N Elango; E Norrby; S Venkatesan
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

6.  Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells.

Authors:  M M Matzuk; M Krieger; C L Corless; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant.

Authors:  D M Kingsley; K F Kozarsky; L Hobbie; M Krieger
Journal:  Cell       Date:  1986-03-14       Impact factor: 41.582

8.  A cowpox virus gene required for multiplication in Chinese hamster ovary cells.

Authors:  D Spehner; S Gillard; R Drillien; A Kirn
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Kinetics of synthesis of respiratory syncytial virus glycoproteins.

Authors:  B F Fernie; G Dapolito; P J Cote; J L Gerin
Journal:  J Gen Virol       Date:  1985-09       Impact factor: 3.891

10.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Authors:  B R Murphy; B S Graham; G A Prince; E E Walsh; R M Chanock; D T Karzon; P F Wright
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

View more
  39 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.

Authors:  Michael N Teng; Peter L Collins
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies.

Authors:  P Rueda; T Delgado; A Portela; J A Melero; B García-Barreno
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.

Authors:  W M Sullender; M A Mufson; L J Anderson; G W Wertz
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008.

Authors:  Ortwin Adams; Judith Werzmirzowsky; Hartmut Hengel
Journal:  Virus Genes       Date:  2013-06-18       Impact factor: 2.332

6.  O glycosylation of glycoprotein G of human respiratory syncytial virus is specified within the divergent ectodomain.

Authors:  P L Collins
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.

Authors:  J S Kahn; A Roberts; C Weibel; L Buonocore; J K Rose
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons.

Authors:  S R Roberts; D Lichtenstein; L A Ball; G W Wertz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 9.  IgA nephropathy enigma.

Authors:  Jiri Mestecky; Jan Novak; Zina Moldoveanu; Milan Raska
Journal:  Clin Immunol       Date:  2016-07-18       Impact factor: 3.969

10.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.